Connor, Clark & Lunn Investment Management (CC&L)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-357,086
| Closed | -$2.79M | – | 1559 |
|
|
2025
Q4 | $2.79M | Sell |
357,086
-491,476
| -58% | -$3.55M | 0.01% | 833 |
|
|
2025
Q3 | $6.44M | Sell |
848,562
-409,129
| -33% | -$3.41M | 0.02% | 514 |
|
|
2025
Q2 | $11.3M | Buy |
1,257,691
+215,267
| +21% | +$2M | 0.04% | 367 |
|
|
2025
Q1 | $7.82M | Buy |
1,042,424
+408,560
| +64% | +$3.3M | 0.03% | 380 |
|
|
2024
Q4 | $4.77M | Sell |
633,864
-48,460
| -7% | -$368K | 0.02% | 494 |
|
|
2024
Q3 | $5.19M | Sell |
682,324
-100,340
| -13% | -$763K | 0.03% | 422 |
|
|
2024
Q2 | $4.84M | Buy |
782,664
+63,222
| +9% | +$349K | 0.02% | 434 |
|
|
2024
Q1 | $3.65M | Buy |
719,442
+27,744
| +4% | +$156K | 0.02% | 503 |
|
|
2023
Q4 | $4.14M | Buy |
691,698
+148,922
| +27% | +$863K | 0.02% | 480 |
|
|
2023
Q3 | $3.84M | Buy |
542,776
+141,567
| +35% | +$1.02M | 0.02% | 455 |
|
|
2023
Q2 | $2.82M | Buy |
401,209
+53,598
| +15% | +$430K | 0.01% | 519 |
|
|
2023
Q1 | $2.9M | Buy |
347,611
+319,815
| +1,151% | +$3.08M | 0.02% | 477 |
|
|
2022
Q4 | $319K | Buy |
+27,796
| New | +$347K | ﹤0.01% | 972 |
|
|
2022
Q2 | – | Sell |
-92,430
| Closed | -$1.5M | – | 1045 |
|
|
2022
Q1 | $1.5M | Buy |
+92,430
| New | +$1.48M | 0.01% | 570 |
|
|
2021
Q3 | – | Sell |
-48,352
| Closed | -$764K | – | 1042 |
|
|
2021
Q2 | $764K | Buy |
+48,352
| New | +$657K | ﹤0.01% | 710 |
|
|
2020
Q2 | – | Sell |
-611,934
| Closed | -$1.22M | – | 1015 |
|
|
2020
Q1 | $1.22M | Buy |
611,934
+434,452
| +245% | +$1.2M | 0.01% | 519 |
|
|
2019
Q4 | $612K | Buy |
+177,482
| New | +$446K | ﹤0.01% | 630 |
|
|
2018
Q2 | – | Sell |
-16,253
| Closed | -$78K | – | 1031 |
|
|
2018
Q1 | $78K | Sell |
16,253
-21,275
| -57% | -$109K | ﹤0.01% | 695 |
|
|
2017
Q4 | $184K | Sell |
37,528
-11,327
| -23% | -$54.9K | ﹤0.01% | 726 |
|
|
2017
Q3 | $256K | Buy |
+48,855
| New | +$250K | ﹤0.01% | 726 |
|
|
2016
Q3 | – | Sell |
-133,005
| Closed | -$378K | – | 838 |
|
|
2016
Q2 | $378K | Sell |
133,005
-68,568
| -34% | -$213K | ﹤0.01% | 637 |
|
|
2016
Q1 | $570K | Sell |
201,573
-5,000
| -2% | -$22.2K | ﹤0.01% | 547 |
|
|
2015
Q4 | $2.13M | Sell |
206,573
-31,700
| -13% | -$315K | 0.02% | 329 |
|
|
2015
Q3 | $2.72M | Buy |
238,273
+147,775
| +163% | +$1.97M | 0.02% | 261 |
|
|
2015
Q2 | $1.35M | Sell |
90,498
-70,100
| -44% | -$797K | 0.01% | 292 |
|
|
2015
Q1 | $1.45M | Sell |
160,598
-52,500
| -25% | -$544K | 0.01% | 265 |
|
|
2014
Q4 | $2.59M | Buy |
213,098
+43,700
| +26% | +$483K | 0.02% | 207 |
|
|
2014
Q3 | $1.66M | Buy |
169,398
+20,000
| +13% | +$245K | 0.01% | 233 |
|
|
2014
Q2 | $2.03M | Sell |
149,398
-378,700
| -72% | -$3.68M | 0.01% | 245 |
|
|
2014
Q1 | $6.17M | Buy |
528,098
+211,220
| +67% | +$2.25M | 0.05% | 146 |
|
|
2013
Q4 | $2.56M | Buy |
+316,878
| New | +$2.01M | 0.02% | 231 |
|
|
2013
Q3 | – | Sell |
-111,800
| Closed | -$183K | – | 527 |
|
|
2013
Q2 | $183K | Buy |
+111,800
| New | +$193K | ﹤0.01% | 477 |
|
Other funds holding BCRX
RCM
DM
VPM
VCM
TCM
PA
VPC